KospicyKorean filings in English
Companies / AbClon

AbClon

앱클론(주)

KOSDAQ · 174900KSIC 213FY ends month 12Separate statementsMarket view
Revenue (TTM)
5.5 bn
Revenue growth
45.0%
Operating margin
-330.4%
Net margin
-321.6%
ROE
-45.0%
Debt / equity
0.14x

Quarterly results

KRW bn2024 Q42025 Q12025 Q22025 Q32025 Q42026 Q12026 Q22026 Q3
Revenue0.70.41.11.61.60.41.71.8
Operating income-3.2-5.8-3.3-3.5-5.0-3.1-6.3-3.9
Net income-3.3-6.0-3.5-3.5-5.1-2.8-6.1-3.8
Cash from operations-3.0-6.4-3.0-2.2-2.2-3.2-6.0-4.5
Free cash flow-3.0-6.9-3.0-2.2-2.4-3.2-6.1-4.5

Annual results

KRW bn202320242025
Revenue2.92.34.7
Operating income-11.6-15.6-17.6
Net income-12.9-16.3-17.9
Cash from operations-9.5-14.4-13.8
Free cash flow-9.5-14.6-14.4

Other ratios trailing 12 months

Gross margin12.0%
ROA-36.3%
Liabilities / equity0.19x
Current ratio4.13x
FCF margin-294.0%
CFO / net income0.90x
Net debt (KRW)-24.7 bn

Recent filings

FilingForm
Fri 13 Nov 2026
Quarterly Report — 2026.0910-QDART
Fri 30 Oct 2026
Material Information for Investment Decisions
투자판단관련주요경영사항 (TIGIT 표적 항체신약 후보물질 도출 공동연구개발 및 기술이전의 건)
8-KDART
[Amendment] Single Sales / Supply Contract — Voluntary8-K/ADART